S100A9 and rheumatoid arthritis: S100A8 and S100A9 are considered biomarkers of disease activity in chronic inflammatory pathologies associated with impaired matrix remodeling such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and cystic fibrosis22.